Augusta, GEORGIA2 Active Studies

Chronic Myeloid Leukemia Clinical Trials in Augusta, GEORGIA

Find 2 actively recruiting chronic myeloid leukemia clinical trials in Augusta, GEORGIA. Connect with local research sites and explore new treatment options.

2
Active Trials
2
Sponsors
209
Enrolling

Recruiting Chronic Myeloid Leukemia Studies in Augusta

About Chronic Myeloid Leukemia Clinical Trials in Augusta

Chronic myeloid leukemia (CML) is a type of cancer that starts in blood-forming cells of the bone marrow, characterized by the Philadelphia chromosome and BCR-ABL fusion gene. It was one of the first cancers treated successfully with targeted therapy. Tyrosine kinase inhibitors like imatinib have transformed CML into a manageable chronic condition.

There are currently 2 chronic myeloid leukemia clinical trials recruiting participants in Augusta, GEORGIA. These studies are seeking a combined 209 participants. Research is being sponsored by Kartos Therapeutics, Inc., Augusta University. Clinical trial participation is free and participants receive study-related medical care at no cost.

Chronic Myeloid Leukemia Clinical Trials in Augusta — FAQ

Are there chronic myeloid leukemia clinical trials in Augusta?

Yes, there are 2 chronic myeloid leukemia clinical trials currently recruiting in Augusta, GEORGIA. Browse the studies on this page to find one that fits.

How do I join a clinical trial in Augusta?

Browse the studies listed above, click one that interests you, and complete the free eligibility form. A study coordinator at the Augusta research site will contact you about next steps.

Are clinical trials in Augusta free?

Yes, clinical trial participation is always free. Study-related treatment, medical tests, and doctor visits are provided at no cost. Many Augusta studies also compensate for your time and travel.

What chronic myeloid leukemia treatments are being tested?

The 2 active trials in Augusta are testing new therapies including novel drugs, biologics, and treatment approaches for chronic myeloid leukemia.

Data updated March 2, 2026 from ClinicalTrials.gov